UPA - UPRET 60mg (Retatrutide) | Self-Mix Vial

Price: R3,199.00
No tax

UPRET 60mg

Retatrutide

1 x 60mg Multi-Dose Vial

1 x 2ml Bacteriostatic Water Ampoule

UPRET 60mg Retatrutide | Self-Mix Vial

UPA UPRET 60mg is a self-mix vial labelled as containing 60mg of retatrutide. Retatrutide is an investigational triple hormone receptor agonist that activates GIP, GLP-1 and glucagon receptors involved in appetite, glucose regulation and energy metabolism.


What UPRET 60mg Is Used For

Retatrutide is currently being researched for:

Supporting significant body-weight reduction

Helping to reduce appetite and food intake

Supporting blood-glucose control

Improving certain metabolic health markers

Supporting the management of obesity and related metabolic conditions

Phase 3 trials have reported substantial weight reduction, but retatrutide remains investigational and is not yet an approved medicine.


How UPRET 60mg Works

Retatrutide simultaneously activates three metabolic hormone receptors:

GLP-1 receptors – involved in appetite, satiety and glucose regulation

GIP receptors – involved in insulin response and metabolic regulation

Glucagon receptors – involved in energy metabolism and expenditure

This triple-receptor activity distinguishes retatrutide from single- and dual-receptor incretin therapies.


How to Use UPRET 60mg

As a self-mix vial, the product requires appropriate reconstitution before administration.

Retatrutide remains investigational, so there is currently no regulator-approved dosing schedule for commercially sold retatrutide products.

Administration Route: In clinical trials, retatrutide is administered by subcutaneous injection once weekly.


Dosage Information

Total labelled content per vial: 60mg Retatrutide

Clinical trials have evaluated several doses using gradual dose escalation. Because retatrutide remains investigational, dosing should not be assumed from non-approved product instructions and should be discussed with a qualified healthcare professional.


Possible Side Effects

Clinical studies have most commonly reported gastrointestinal side effects, particularly during dose escalation.

Common

Nausea

Diarrhoea

Vomiting

Constipation

Decreased appetite

  • Brand

Comments (0)

No customer reviews for the moment.

4 other products in the same category

Loading...
Back to top